News >

BRCA Gene Does Not Predict Poor Prognosis in Patients With Breast Cancer

Beth Fand Incollingo @fandincollingo
Published: Tuesday, Jan 10, 2017

Diana Eccles, MB, ChB, MD, FRCP

Diana Eccles, MB, ChB, MD, FRCP

While mutations of the BRCA gene can increase a woman’s chances of developing breast and ovarian cancers, the presence of the gene made no difference in survival for women aged 40 years or younger who were diagnosed with early-stage breast cancer, according to a recent study that followed participants for approximately 8 years. These findings were presented at the 2016 San Antonio Breast Cancer Symposium in December.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances In™ Tumor Testing: Interpreting Genomic Profiles to Optimize Breast Cancer TreatmentJun 29, 20191.5
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x